Aducanumab for Alzheimer’s, really?

The FDA’s advisory board is considering to approve the Biogen’s Aducanumab for Alzheimer’s therapy, again, after years “reorganizing” the clinical data. One says the possible mechanism is to help open the canal for garbage plaque to leave...

Is glucose good or bad for Alzheimer’s?

Many recent clinical and research results show deprivation of glucose in brain to cause early stage Alzheimer’s disease, such as the study published on 1-31-2017 by the researchers in the medical school of Temple University. However, some study results may cause...